Simvastatin inhibits interferon-γ-induced MHC class II up-regulation in cultured astrocytes

Based on their potent anti-inflammatory properties and a preliminary clinical trial, statins (HMG-CoA reductase inhibitors) are being studied as possible candidates for multiple sclerosis (MS) therapy. The pathogenesis of MS is unclear. One theory suggests that the development of autoimmune lesions...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Zeinstra, Esther, Wilczak, Nadine, Chesik, Daniel, Glazenburg, Lisa, Kroese, Frans GM, De Keyser, Jacques
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2006
Témata:
Short Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1544322/
https://ncbi.nlm.nih.gov/pubmed/16859542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-2094-3-16
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky